Inhibitor

(redirected from reverse transcriptase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.
Related to reverse transcriptase inhibitor: NNRTI, NRTI

inhibitor

[in′hib·əd·ər]
(aerospace engineering)
A substance bonded, taped, or dip-dried onto a solid propellant to restrict the burning surface and to give direction to the burning process.
(chemistry)
A substance which is capable of stopping or retarding a chemical reaction; to be technically useful, it must be effective in low concentration.

Inhibitor

 

a circuit having m + n inputs and a single output, at which a signal can appear only when there are no signals on the m inputs (inhibiting). The other n inputs (principal) form one of the two logic connections, “AND” or “OR.” Inhibitors are used extensively in computers. They are very often understood to be a circuit having a single principal input and a single inhibiting input. A signal appears at the output of such a circuit when a signal is present on the principal input but there is none on the inhibiting input. Such an inhibitor is called an anticoincidence gate; its conventional representation is given in Figure 1.

Figure 1. Block diagram of an anticoincidence gate (inhibitor) with m — 1 and n 1:(A) principal input, (Q) inhibiting input, (Ga) anticoincidence gate

inhibitor

A substance added to paint to retard drying, skinning, mildew growth, etc. Also see corrosion inhibitor, inhibiting pigment, drying inhibitor.
References in periodicals archive ?
In addition, Merck announced plans to advance into Phase IIb clinical trial an internally developed candidate, MK-1439, a next-generation non-nucleoside reverse transcriptase inhibitor.
In this study, 61 percent of 57 pediatric patients who took Sustiva in combination with nelfinavir and nucleoside reverse transcriptase inhibitors, achieved HIV-RNA greater than 400 copies/mL after 20 weeks of treatment.
It at first restricted entry to persons with viral loads over 10,000 and CD4 counts under 100 -- plus documented treatment failure with at least two protease inhibitors or one PI and one non-nucleoside reverse transcriptase inhibitor (NNRTI).
Nevirapine also is a non-nucleoside reverse transcriptase inhibitor, but differs significantly in chemical structure from BHAP compounds.
The product contains 600 mg of efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate, both nucleoside reverse transcriptase inhibitors (NRTIs).
Nevirapine, a non-nucleoside reverse transcriptase inhibitor, continues to be studied in combination with AZT for the treatment of HIV infection.
Yesterday, October 31, 00, FDA approved a new formulation of the nucleoside reverse transcriptase inhibitor, ddI, called VIDEX EC.
Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI).
amp; HUDDINGE, Sweden -- Bristol-Myers Squibb Company (NYSE:BMY) and Medivir AB (STO:MVIRb) today announced a worldwide collaboration to develop and commercialize MIV-170, a preclinical non-nucleoside reverse transcriptase inhibitor, or NNRTI, intended for the treatment of HIV-1 infection in adults as part of an antiretroviral drug regimen.
The drug is a nucleoside reverse transcriptase inhibitor (NRTI), manufactured and distributed by Bristol-Myers Squibb.
Zalcitabine is a nucleoside reverse transcriptase inhibitor (NRTI).

Full browser ?